Liddy James Gordon
SEC insider (Form 3/4/5 filer). CIK 0002082917. Director at Hepion Pharmaceuticals, Inc. (HEPA) and 1 other issuer. 2 reported Form 4/5 transactions since Sep 2024; latest on Aug 19, 2026. Located in RED BANK,, NJ.
Companies Liddy James Gordon has filed insider reports for
- Hepion Pharmaceuticals, Inc. (HEPA): Director
- Tharimmune, Inc. (THAR): Director
Liddy James Gordon
CIK: 0002082917
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
